Sacheerome

Why is Sacheerome Ltd falling/rising?

As of 11-Jun, Sacheerome Ltd's stock price is rising to 343.75, reflecting a 2.34% increase. This rise is driven by strong daily performance and a significant weekly gain, despite a year-to-date decline and reduced investor participation.

As of 11-Jun, Sacheerome Ltd's stock price is rising, currently at 343.75, which reflects a change of 7.85 or 2.34% increase. This upward movement can be attributed to its strong performance today, where it outperformed the sector by 4.11%. Additionally, the stock has shown a significant increase of 11.08% over the past week, contrasting with a decline of 1.09% in the Sensex during the same period. <BR><BR>Despite a year-to-date decline of 9.88%, the stock's current price is higher than its 5-day, 20-day, 50-day, and 200-day moving averages, indicating a positive short-term trend. However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 50.34% against the 5-day average. This could suggest that while the stock is currently rising, there may be underlying concerns regarding sustained investor interest. Overall, the combination of today's performance and recent weekly gains contributes to the stock's rising price.

Which are the latest news on Sacheerome?

What does Sacheerome do?

Sacheerome Ltd is a micro-cap company in the specialty chemicals industry with no reported sales or profits. It has a market cap of INR 761 Cr, a P/E ratio of 26.00, and a return on equity of 19.16%.

Overview: <BR>Sacheerome Ltd operates in the specialty chemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>No specific details regarding the incorporation year or status changes are available. Additionally, there is no sales or profit data reported for any quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 761 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 26.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.30 <BR>Return on Equity: 19.16% <BR>Price-to-Book: 5.22 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Sacheerome?

Sacheerome's peers include Indo Amines, Gem Aromatics, Valiant Organics, Fairchem Organic, Chemcon Special., Jayant Agro Org., DMCC Speciality, Sudarshan Pharma, and Amal. Sacheerome exhibits excellent management and growth, while its peers generally show average to below-average performance, with Chemcon Special. having the highest 1-year return at -6.16%.

Peers: The peers of Sacheerome are Indo Amines, Gem Aromatics, Valiant Organics, Fairchem Organic, Chemcon Special., Jayant Agro Org., DMCC Speciality, Sudarshan Pharma, and Amal.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sacheerome, while Average management risk is found at Indo Amines, Gem Aromatics, Valiant Organics, Fairchem Organic, Jayant Agro Org., and DMCC Speciality, and the rest. Growth is Excellent at Sacheerome and Sudarshan Pharma, while Below Average growth is noted at Indo Amines, Gem Aromatics, Valiant Organics, Fairchem Organic, Jayant Agro Org., DMCC Speciality, and the rest. Capital Structure is Excellent at Sacheerome and Chemcon Special., Good at Gem Aromatics and Fairchem Organic, Average at Valiant Organics, Jayant Agro Org., and DMCC Speciality, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Chemcon Special. at -6.16%, while Valiant Organics has the lowest at -44.32%. Sacheerome's 1-year return is not available for comparison. Additionally, the six-month return is negative for Indo Amines, Valiant Organics, Fairchem Organic, Chemcon Special., DMCC Speciality, and Sudarshan Pharma.

How has been the historical performance of Sacheerome?

Sacheerome has shown consistent growth from March 2023 to March 2025, with net sales increasing from 70.49 Cr to 107.54 Cr and profit after tax rising from 5.99 Cr to 15.98 Cr, indicating strong operational efficiency and profitability. Total assets and shareholder's funds also grew significantly, reflecting a solid financial foundation.

Answer:<BR>The historical performance of Sacheerome shows a consistent growth trend across various financial metrics from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Sacheerome's net sales increased from 70.49 Cr in March 2023 to 107.54 Cr in March 2025, reflecting a strong upward trajectory. Total operating income followed suit, rising from 70.49 Cr to 107.54 Cr during the same period. The company's total expenditure also grew, from 60.57 Cr in March 2023 to 85.12 Cr in March 2025, driven by rising raw material costs and other expenses. Operating profit, excluding other income, improved significantly from 9.92 Cr to 22.42 Cr, indicating enhanced operational efficiency. Profit before tax surged from 8.34 Cr to 21.42 Cr, and profit after tax rose from 5.99 Cr to 15.98 Cr, demonstrating robust profitability growth. The earnings per share (EPS) increased from 14.68 to 9.79, while the PAT margin improved from 8.5% to 14.86%. On the balance sheet, total assets grew from 47.89 Cr to 83.27 Cr, and shareholder's funds increased from 35.34 Cr to 61.99 Cr, indicating a solid financial foundation. The cash flow from operating activities also showed improvement, rising from 9.00 Cr to 22.00 Cr, while net cash inflow reached 1.00 Cr by March 2025. Overall, Sacheerome's financial performance reflects significant growth and strengthening of its financial position over the observed period.

Is Sacheerome overvalued or undervalued?

As of September 17, 2025, Sacheerome is considered "very expensive" and overvalued with a PE Ratio of 33.32, an EV to EBITDA of 23.35, and a Price to Book Value of 8.59, indicating high valuation relative to earnings and assets, despite outperforming the Sensex recently.

As of 17 September 2025, Sacheerome has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued based on its financial metrics. Key ratios include a PE Ratio of 33.32, an EV to EBITDA of 23.35, and a Price to Book Value of 8.59, all of which suggest a high valuation relative to earnings and assets.<BR><BR>In comparison to its peers, Sacheerome's valuation stands out, particularly against Solar Industries with a PE of 106.01 and Godrej Industries at 40.66. This indicates that while Sacheerome is expensive, it is not the highest in its sector. Additionally, despite its recent stock performance showing a 24.52% return over the past week compared to a 1.43% return of the Sensex, the overall valuation metrics suggest that Sacheerome is not justified at its current price level.

How big is Sacheerome?

As of 25th March, Sacheerome Ltd does not have a market capitalization value available and lacks financial data for the latest four quarters. The latest balance sheet shows Shareholder's Funds at 61.99 Cr and Total Assets at 83.27 Cr as of March 2025.

As of 25th March, Sacheerome Ltd does not have a market capitalization value available, therefore it cannot be classified into any market cap type.<BR><BR>There is no valid financial data available for the latest four quarters, so Net Sales and Net Profit figures cannot be provided.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds reported at 61.99 Cr and Total Assets at 83.27 Cr.

Who are the top shareholders of the Sacheerome?

The top shareholder of Sacheerome is Manoj Arora, who holds 51.18%. Other notable shareholders include Bharat Venture Opportunities Fund at 2.19%, individual investors with 12.55%, and 35 foreign institutional investors holding a total of 1.46%.

The top shareholders of Sacheerome include the promoters, with Manoj Arora holding the highest stake at 51.18%. There are no pledged promoter holdings. In terms of public shareholders, Bharat Venture Opportunities Fund is the largest, holding 2.19%. Additionally, individual investors collectively hold 12.55%, and the company has 35 foreign institutional investors (FIIs) with a combined holding of 1.46%.